Finerenone Reduces Renal RORγt γδ T Cells and Protects against Cardiorenal Damage
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Nephrology"
DOI: 10.1159/000524940
Abstract: Introduction: Chronic activation of the mineralocorticoid receptor (MR) leads to pathological processes like inflammation and fibrosis during cardiorenal disease. Modulation of immunological processes in the heart or kidney may serve as a mechanistic and therapeutic… read more here.
Keywords: ror; finerenone; renal ror; doca salt ... See more keywords